TAO Connect Raises $460k in Funding
TAO Connect, a St. Petersburg, FL-based provider of a suite of online management tools for therapists, raised $460k in funding.
TAO Connect, a St. Petersburg, FL-based provider of a suite of online management tools for therapists, raised $460k in funding.
O2 RegenTech, a an Akron, OH-based medical technology company focused on wound care solutions, raised $600k in funding.
Nyca Partners, a NYC-based venture capital firm focused on applying innovation in financial services into the global financial system, closed its latest fund, at over $125m.
UberCloud, a Los Altos, CA-based cloud marketplace for engineers, scientists and service providers to discover, try, and buy computing on demand, raised $1.7m in funding.
Koru Kids, a London, UK-based nanny sharing platform, raised £600k in seed funding.
MIOAssicuratore, a Rome, Italy-based insurtech startup, raised €300k in funding.
Guest Post by the Observatory of P101 According to TechCrunch experts, by the year 2018 our smartphones will be able to support virtual reality and augmented reality.
Venrock, a NYC, Boston, MA and Palo Alto, California-based technology and healthcare focused venture capital firm, closed its latest fund, at $450m.
Zappix, a Burlington, MA-based smartphone Visual Interactive Voice Response software provider, secured a new round of financing.
Allinaire Therapeutics LLC, an Indianapolis, IN-based life sciences startup company focusing on novel therapeutics for pulmonary diseases, received a seed funding of undisclosed amount.
Adlatus Robotics, an Ulm-based service robotics startup, raised a seed financing round of undisclosed amount.
Cellestia Biotech AG, a Basel, Switzerland – based private biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway, closed a CHF8m financing round.
According to CB Insights, vc activity related to insurance startups hit its highest annual total in 2016 with $1.69B invested in 173 deals.
Biscayne Neurotherapeutics, a Miami, FL-based clinical-stage biotechnology company, raised over US$3m in Series B funding.
Verily Life Sciences, a South San Francisco, CA, USA-based Alphabet company that provides healthcare solutions for global markets, received an $800M investment.